No Data
No Data
Is ATRenew Inc. (NYSE:RERE) Worth US$2.3 Based On Its Intrinsic Value?
Today we will run through one way of estimating the intrinsic value of ATRenew Inc. (NYSE:RERE) by estimating the company's future cash flows and discounting them to their present value.
NIO and WOOF Among Consumer Discretionary Movers
Earnings Call Summary | ATRenew(RERE.US) Q1 2024 Earnings Conference
The following is a summary of the ATRenew Inc. (RERE) Q1 2024 Earnings Call Transcript:Financial Performance:ATRenew reported a 27.1% increase in total revenues for Q1 2024, reaching RMB3.65 billion.
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Virios Therapeutics, Inc. (NASDAQ:VIRI) fell sharply during Monday's session after the company priced a $1.7 million public offering of 8.5 million shares of common stock at $0.20 per share.
ATRenew Shares Fall After Lower Q1 Adjusted Earnings
ATRenew (RERE) shares fell more than 4% in recent Monday trading after the company reported Q1 adjusted net income of 0.13 renminbi ($0.02) per diluted share, down from 0.30 renminbi a year ago.
12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session
GainersFaraday Future (NASDAQ:FFIE) shares moved upwards by 80.6% to $1.86 during Monday's pre-market session. The company's market cap stands at $79.3 million. Jiuzi Hldgs (NASDAQ:JZXN) shares increa
No Data